On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes
- PMID: 9820462
- DOI: 10.1053/ajkd.1998.v32.pm9820462
On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes
Abstract
Hundreds of thousands of individuals are alive today because of the availability of dialysis for the treatment of patients with end-stage renal disease (ESRD). From the outset, it was evident that this was a costly therapy and would require specialized training. The federal government responded by providing financial support and medicine by establishing the discipline of nephrology to provide specialized training. As a result, the center stage that ESRD has come to occupy was dictated by a successful treatment in the purview of a new discipline by a model and well-intentioned, but restrictive, law that provided support only to the terminal stage of kidney disease. That this natural evolution was short-sighted has become a belated, but well-deserved, focus of attention. The care of chronic renal disease (CRD) patients cannot start after the onset of ESRD when renal replacement therapy is initiated but must be set into motion when renal failure first begins to exert its detrimental effects on the metabolic balance, function, and structure of the body. Attentive care is needed throughout the course of progressive renal failure, because once CRD begins to progress, there is an increasing number of detrimental consequences whose cumulative burden will exert its ravages on the body simultaneously with that of the ongoing loss of renal function. Consequently, the patient with CRD who presents in ESRD has already sustained considerable, often irreversible, loss of body function. Preventive measures to circumvent this eventuality are most effective, cost-efficient, and of greatest benefit when instituted early in the course of progressive CRD. This is probably truest of cardiovascular disease, which is the leading cause of mortality of patients on dialysis and following transplantation. The report of the National Kidney Foundation Task Force on Cardiovascular Disease in CRD is a first attempt to promulgate and provide evidence-based recommendations for this holistic approach to the care of patients with renal disease.
Similar articles
-
[REIN Report 2011--summary].Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1. Nephrol Ther. 2013. PMID: 24119584 French.
-
Forum of the End-Stage Renal Disease Networks' role in implementing the National Kidney Foundation-Dialysis Outcomes Quality Initiative Clinical Practice Guidelines.Adv Ren Replace Ther. 1999 Jan;6(1):28-35. doi: 10.1016/s1073-4449(99)70005-1. Adv Ren Replace Ther. 1999. PMID: 9925147
-
Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.Am J Kidney Dis. 2017 Nov;70(5):705-714. doi: 10.1053/j.ajkd.2017.06.025. Epub 2017 Aug 12. Am J Kidney Dis. 2017. PMID: 28811048 Free PMC article.
-
Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure.Am J Kidney Dis. 1998 Mar;31(3):398-417. doi: 10.1053/ajkd.1998.v31.pm9506677. Am J Kidney Dis. 1998. PMID: 9506677 Review.
-
Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions.Am J Kidney Dis. 1998 Nov;32(5):705-19. doi: 10.1016/s0272-6386(98)70146-5. Am J Kidney Dis. 1998. PMID: 9820438 Review.
Cited by
-
Multidisciplinary team care may slow the rate of decline in renal function.Clin J Am Soc Nephrol. 2011 Apr;6(4):704-10. doi: 10.2215/CJN.06610810. Epub 2011 Jan 27. Clin J Am Soc Nephrol. 2011. PMID: 21273376 Free PMC article.
-
Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease.Drug Saf. 2000 May;22(5):350-60. doi: 10.2165/00002018-200022050-00003. Drug Saf. 2000. PMID: 10830252 Review.
-
Is There any Time Dependant Echocardiographical Finding in Chronic Hemodialysis Patients?Cardiol Res. 2012 Dec;3(6):271-276. doi: 10.4021/cr241e. Epub 2012 Nov 20. Cardiol Res. 2012. PMID: 28352416 Free PMC article.
-
Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease.Cardiovasc Ultrasound. 2006 Feb 2;4:9. doi: 10.1186/1476-7120-4-9. Cardiovasc Ultrasound. 2006. PMID: 16457710 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials